Search Result "myelosuppression"
Cancer Therapy-Induced Residual Bone Marrow Injury: Mechanisms of Induction and Implication for Therapy
Journal: Current Cancer Therapy Reviews
Volume: 2 Issue: 3 Year: 2006 Page: 271-279
Author(s): Yong Wang, Virginia Probin, Daohong Zhou
Toxicity and Efficacy of Benzamide Riboside in Cancer Chemotherapy Models
Journal: Current Medicinal Chemistry
Volume: 9 Issue: 7 Year: 2002 Page: 787-792
Author(s): Hiremagalur N. Jayaram, Joel A. Yalowitz, Francisco Arguello, John F. Greene,Jr
Cytoprotection and Immunomodulation in Cancer Therapy
Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 4 Issue: 6 Year: 2004 Page: 479-490
Author(s): Sham Diwanay, Manish Gautam, Bhushan Patwardhan
The Safety of the Temozolomide in Patients with Malignant Glioma
Journal: Current Drug Safety
Volume: 1 Issue: 2 Year: 2006 Page: 205-222
Author(s): Alessandro Dario, Giustino Tomei
Effect and Mechanism of Specnuezhenide on Chemotherapy-inducedMyelosuppression
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 26 Issue: 13 Year: 2023 Page: 2393-2400
Author(s):
A Prospective Study on the Incidence and Severity of Paclitaxel-inducedPeripheral Neuropathy in the Indian Population
Journal: Current Cancer Therapy Reviews
Volume: 18 Issue: 4 Year: 2022 Page: 278-284
Author(s):
Pegfilgrastim-Apgf (Nyvepria): Biosimilar USFDA Approval for theTreatment of Chemotherapy-induced Febrile Neutropenia and CurrentUpdates on Clinical Trials
Journal: Current Drug Targets
Volume: 23 Issue: 9 Year: 2022 Page: 924-932
Author(s):
Irinotecan for Treatment of Childhood Cancers: A Promising Therapeutic Partner
Journal: Current Cancer Therapy Reviews
Volume: 6 Issue: 4 Year: 2010 Page: 283-293
Author(s): Lars Wagner
Polymer Nanoparticles - A Novel Strategy for Administration of Paclitaxel in Cancer Chemotherapy
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 3 Year: 2012 Page: 6207-6213
Author(s): G. Deepa, N. Ashwanikumar, J. J. Pillai, G. S.V. Kumar
Immunomodulatory Drugs as a Therapy for Multiple Myeloma
Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 6 Year: 2006 Page: 415-421
Author(s): H. De Raeve, K. Vanderkerken